Science & Enterprise subscription

Follow us on Twitter

  • A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is ra… https://t.co/LFNVxych8d
    about 5 hours ago
  • New post on Science and Enterprise: New Allergy Biotech Launches, Raises $10M https://t.co/x5W0TwnCBu #Science #Business
    about 5 hours ago
  • Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 inf… https://t.co/LaUrUiRmhk
    about 24 hours ago
  • New post on Science and Enterprise: Trial Set for Covid-19 Antibodies in Long-Term Care https://t.co/tF0a7CDgGr #Science #Business
    about 24 hours ago
  • The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 a… https://t.co/AO2DxxTgF8
    about 1 day ago

Please share Science & Enterprise

Trial Underway for Seasonal Flu Antibody Therapy

Cattle

A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza. . . . → Read More: Trial Underway for Seasonal Flu Antibody Therapy

Synthetic Protein Maker Raises $91.3M in Venture Funds

Elastapure bottle

A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round. . . . → Read More: Synthetic Protein Maker Raises $91.3M in Venture Funds

Synthetic Protein Designed to Boost Covid-19 Vaccines

Jason McLellan and Daniel Wrapp

Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines. . . . → Read More: Synthetic Protein Designed to Boost Covid-19 Vaccines

Trial Testing Point-of-Care Covid-19 Diagnostic

A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour. . . . → Read More: Trial Testing Point-of-Care Covid-19 Diagnostic

Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Vesicles

A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells. . . . → Read More: Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Gene Therapy Production Company Opens, Raises $40M

Adeno-associated virus

A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds. . . . → Read More: Gene Therapy Production Company Opens, Raises $40M

New Company Offers A.I. Aging Biomarker Analysis

Older couple

A new enterprise is underway using artificial intelligence to analyze a person’s body chemistry and calculate the likelihood of age-related diseases. . . . → Read More: New Company Offers A.I. Aging Biomarker Analysis

Univ. Lab Discovers, Licenses Citrus Disease Treatment

Australian finger lime

Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a disease destroying citrus crops worldwide. . . . → Read More: Univ. Lab Discovers, Licenses Citrus Disease Treatment

Crispr Heart Therapy Demonstrated in Monkeys

Heart and major blood vessels

An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease. . . . → Read More: Crispr Heart Therapy Demonstrated in Monkeys

Engineered Immune, Stem Cells Studied for HIV Cure

HIV released from cell

Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections. . . . → Read More: Engineered Immune, Stem Cells Studied for HIV Cure